EGFR Positive Non-small Cell Lung Cancer (2)

Adenocarcinoma (1)

Recruiting (1)

Unknown status (1)

phase 1 (1)

phase 4 (1)

Ascentage Pharma Group Inc. (1)

Betta Pharmaceuticals Co., Ltd. (1)

Suzhou Yasheng Pharmaceutical Co., Ltd. (1)

apg-1252 (1)

icotinib (1)

osimertinib mesylate tablets (1)

sequential icotinib plus chemotherapy (1)

drug (2)

Industry (2)

Interventional (2)

EGFR Positive Non-small Cell Lung Cancer

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS